EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 4-Sep-2025 17:11 ET (4-Sep-2025 21:11 GMT/UTC)

New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer

Society of Nuclear Medicine and Molecular Imaging
Peer-Reviewed Publication

Two molecular targets—human epidermal growth factor 2 (HER2) and cluster of differentiation 24 (CD24)—are highly promising candidates for new nuclear diagnostics and therapeutics for endometrial cancer, according to new research published in The Journal of Nuclear Medicine. PET imaging of these targets could play a significant role in the management of the disease, helping clinicians identify patients who are likely to respond to targeted therapeutics.

Journal: Journal of Nuclear Medicine

Sizing up a weakness in synovial sarcoma’s genes

Sanford Burnham Prebys
Peer-Reviewed Publication

New research shows that using a drug as a blocker to outcompete the small ubiquitin-like modifier 2 (SUMO2) protein may be a winning strategy against an aggressive cancer called synovial sarcoma.

Journal: The EMBO Journal

C-Path’s Translational Therapeutics Accelerator marks record year with seven BRIDGe awards advancing potential therapies across cancer, infectious disease, neurology and immunology

Critical Path Institute (C-Path)
Grant and Award Announcement

Critical Path Institute® announced today that its Translational Therapeutics Accelerator (TRxA) program has completed a record year of funding and mentorship, making seven BRIDGe awards to academic drug-development teams. TRxA launched in 2022 and awarded its first grants in 2023. In 2025 the program supported seven projects, its largest annual cohort.

In extensive sequencing study, scientists find few links between cancer and microbiome

Johns Hopkins Medicine
Peer-Reviewed Publication

About a dozen studies in the past five years have made claims linking nearly every type of human cancer with the presence of microbiomes, “communities” of bacteria, viruses and fungi that live in or on peoples’ bodies. Now, scientists at Johns Hopkins Medicine say a study that sequenced human cancers found far less microbial DNA sequences than earlier studies reported in the same cancer tissue samples.

Journal: Science Translational Medicine
Funder: NIH/National Institutes of Health, NIH/National Institutes of Health

Scientists discover how brain fluid movement drives cancer spread and ways to fight back

The Hospital for Sick Children
Peer-Reviewed Publication

Researchers have uncovered how cerebrospinal fluid dynamics in the brain play an important role in driving the spread of medulloblastoma and identified a way to target this fluid-driven process to inhibit tumour spread.

ASTRO to showcase advances in radiation medicine and cancer research in 2025 Annual Meeting Press Program

American Society for Radiation Oncology
Meeting Announcement

The American Society for Radiation Oncology (ASTRO) announced today the press program for its 2025 Annual Meeting this month in San Francisco. Researchers will discuss their findings in news briefings on Sept. 29 and 30, and complimentary meeting registration is available for credentialed press. The field's most influential scientific forum, ASTRO's Annual Meeting will feature pivotal studies in radiation medicine for patients with cancer and other diseases.

Meeting: American Society for Radiation Oncology (ASTRO) 2025Annual Meeting

Study shows how smoking drives pancreatic cancer

Michigan Medicine - University of Michigan
Peer-Reviewed Publication

A new study explains why smokers have a higher chance of developing pancreatic cancer and why they tend to have worse outcomes than nonsmokers.

Journal: Cancer Discovery
Funder: NIH/National Cancer Institute, NIH/National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Department of Veterans Affairs

MSK Research Highlights, September 4, 2025

Memorial Sloan Kettering Cancer Center
Peer-Reviewed Publication

New research from Memorial Sloan Kettering Cancer Center (MSK) shows the Make-an-IMPACT program improves global access to genomic testing in pediatric cancer patients; helped develop an experimental antibody that shows promise against metastatic cancer; sheds light on the origins of ERG-driven prostate cancer; and finds Dupilumab is a successful agent to treat skin toxicities related to antibody-drug conjugates.

Dietary changes could provide a therapeutic avenue for brain cancer

Michigan Medicine - University of Michigan
Peer-Reviewed Publication

In a study published in Nature, a team of researchers at the University of Michigan found that glioblastoma tumor cells rewire how they use sugar. When they altered diet in mouse models, it slowed tumor growth — which offers potential for new treatments.

Journal: Nature
Funder: NIH/National Cancer Institute, NIH/National Institute of Neurological Disorders and Stroke, NIH/National Institute of Diabetes and Digestive and Kidney Diseases, University of Michigan, American Cancer Society, NIH/National Institute of General Medical Sciences

CHEMTUBIO, a new ERC project at IBEC to study enzymes with therapeutic potential

Institute for Bioengineering of Catalonia (IBEC)
Grant and Award Announcement

Carlos Moreno Yruela, who is currently a researcher at the Swiss Federal Institute of Technology in Lausanne, Switzerland, was selected in the ERC Starting Grants call to develop the CHEMTUBIO project at the Institute for Bioengineering of Catalonia (IBEC). The project will study the chemistry of enzymes that erase microtubule modifications. These enzymes are essential for the functioning of our cells and have shown great promise as potential therapeutic targets for treating cancer, heart disease and neurological disorders.

1
2
3